| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |